Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd ($874) - buy or sell? Stock discussion, ideas, forum

Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd

Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd.

Industry: Pharmaceuticals

Ticker	Exchange	ISIN	Name
$874	HKEx Main Board	CNE100000387	Code: 874

Recent news

TAI Ping Carpet International Ltd revenue jumped on 34.8% while EBITDA Margin decreased on 2.8 pp from 9.9% to 7.1%

Vision Fame International Holding Ltd revenue growth accelerated from 2.3% in FY2019 to 405% in FY2020

Kantone Holdings Ltd reports 13.0% EBITDA growth in 2020 and 0.61 pp EBITDA Margin growth from 5.7% to 6.3%

Heng Tai Consumables Group Ltd revenue dropped on 35.5% and EBITDA Margin dropped on 19.0 pp from -27.6% to -46.6%

Yat Sing Holdings Ltd revenue decreased on 8.4% and EBITDA Margin decreased on 2.2 pp from -1.7% to -3.9%

Art Textile Technology International Co Ltd Net Debt / EBITDA surged on 82.8x from 3.9x to 86.8x in 2020 while Revenue dropped on 24.7%

China Zenith Chemical Group Ltd revenue dropped on 39.8% while EBITDA Margin surged on 93.4 pp from -149% to -55.4%

Odella Leather Holdings Ltd revenue returned to growth in FY2020: increased 60.4% vs. 48.6% decline a year earliner

New World Development Co Ltd Net Income dropped on 85.3% and Revenue dropped on 23.1%

NWS Holdings Ltd reports 80.3% Net Income decline in 2020 and 3.4% Revenue decline

Twit about 874 stock

Share your investment idea or question on Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd stock:

Latest twits on Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd (874)

No twits yet. Be the first to post!

Have a question about 874? Ask and other investors will be eager to help you.

Have an idea about 874? Share it with other investors.

Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd news

15/03/2017 Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd reports 16.0% Net Income growth and 4.7% Revenue growth

18/03/2016 Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Net Income increased on 8.9% in 2015 and EBITDA Margin showed almost no change

Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd stock price chart

Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd financials

mln. CNY	FY2010	FY2011	FY2012

Revenue	4,456	5,396	11,954
EBITDA	290.0	258.6	837.1
Net income	267.1	287.5	729.0
CAPEX	83.203	58.863	170.0
Debt	115.2	150.4	757.2
Cash	696.3	355.7	1,114

Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd news

About Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd

Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd. manufactures and sells Chinese patent medicine. The Company also wholesales, retails, imports, and exports Western and Chinese pharmaceutical products and various medical apparatus.